In Silico Methods For Drug Discovery Highlighted

November 3, 2000

NEWS BRIEFS

San Diego, CALIF. — The trend towards in silico (computer-based) design and selection of new molecules to improve the efficiency and reduce the cost of drug discovery and development will be a major theme at the American Association of Pharmaceutical Scientists (AAPS) meeting in Indianapolis from October 29 – November 2. At the largest annual gathering of pharmaceutical scientists in the world, Trega Biosciences, Inc., an innovator in modeling systems to simulate how drug candidates will be processed in the body, is presenting data on its absorption model, and “sneak previewing” the capability of its second model to predict metabolism. Absorption and metabolism are the first two modules of Trega’s iDEA Predictive ADME (absorption, distribution, metabolism and excretion) Simulation System.

“We are witnessing a paradigm shift in the pharmaceutical industry concerning the process of making smart decisions about which drugs to develop, and more and more software is becoming available to discovery scientists to enable such decisions earlier in the process,” said Patrick Sinko, Ph.D. Dr. Sinko, Trega’s Chief Scientist of Discovery Technologies, and Professor and Chairman, Department of Pharmaceutics, College of Pharmacy, Rutgers University, is a featured speaker at the AAPS Symposium on “Enabling Technologies for Ensuring Developability.”

Dr. Sinko added: “Much of the estimated cost of $650 million to get a drug to market is not for developing the one successful drug, but for the 90+% of drugs that will fail prior to getting to market. Perhaps the most exciting area, therefore, is in ADME simulation, because an understanding of the bioavailability of a drug in humans is so critical to its downstream success in the clinic. The Trega iDEA Simulation System, for example, offers a tremendous amount of leverage because it can be applied so early in the discovery process. Trega’s initial iDEA absorption module is designed to enable a scientist to use in vitro data to predict drug impact in humans.

Dr. Carleton Sage, Senior Computational Scientist, of Trega Biosciences, et.al., will present a poster on “In silico prediction of Caco-2 permeability from molecular structure.” Caco-2 is an established in vitro method for estimating permeability and an input to the iDEA absorption module. Trega set out to show that if Caco-2 permeability could be predicted using molecular structure, then human absorption properties could be incorporated much earlier in the drug discovery process, thereby eliminating wasteful and expensive testing of poorly absorbed compounds. After generating data on 230 drugs, both marketed and failed, Trega constructed a number of models, the best of which accurately predicts Caco-2 permeability based solely on molecular structure as in input. The experiment validates the premise that synthesis or experimentation may not be necessary first steps to understanding absorption characteristics of compounds.

“Currently, Trega is demonstrating the ability to go from structural data to predict the in vitro outcome. Thus, for the first time ever, the next generation of Trega’s absorption model will provide the research scientist with a design continuum that goes directly and reliably from the molecular structure of a drug on the computer screen to a prediction of the bioavailability of that drug on humans,” Dr. Sinko concluded.

Dr. Glen Leesman, Principal Scientist, of Trega will be presenting data that further validates the premise that Trega’s absorption model accurately predicts drug absorption when applied in a “real-world” pharmaceutical research setting. The accuracy of the model had initially been demonstrated using data provided by a consortium of pharmaceutical companies. The rate and extent of absorption of eight additional drugs, provided by F. Hoffmann LaRoche for this experiment, were then evaluated. The selected drugs had diverse chemical and physical properties and were provided for evaluation with molecular weight as the only form of identity. The Trega model accurately predicted the relevant biopharmaceutical outcomes for all eight drugs. Dr. Leesman’s, et. al., poster is entitled, “Assessment of the physiologically-based iDEA predictive model using an external (blinded) data set.”

“Consistent with our modular design strategy, our scientists have developed the next generation model that uses chemical structure to predict Caco-2 permeability. This feature is particularly applicable in early discovery for in silico screening of large numbers of compounds and significantly expands the scope of solutions that can be addressed by predictive modeling,” said Michael G. Grey, Trega’s President and CEO. “Furthermore, external researchers have validated the utility and reliability of the commercially available physiologically-based iDEA absorption model.”

Trega is developing a predictive model to simulate how a compound is metabolized in the human body and plans to preview elements of the model during the conference. The metabolism model is being developed using in vitro data and human pharmacokinetic data to build predictive relationships. The data required for this model includes the output from the iDEA absorption module and data generated by performing an in vitro hepatocyte assay in the laboratory. The model then predicts the amount of drug that passes through the liver unchanged.

“The development of our metabolism model is representative of our strategy of developing each module with collaborators in pharmaceutical companies. As we recently announced, Janssen Research Foundation and The R.W. Johnson Pharmaceutical Research Institute, members of the Johnson & Johnson family of companies, will collaborate with Trega to further enhance the predictive capabilities of iDEA predictive model,” continued Mr. Grey. “We intend to complete development of the metabolism module by the end of this year with the next release of the iDEA Simulation System. Trega plans to enable the comprehensive in silico prediction of bioavailability with a suite of modules to simulate absorption, metabolism, distribution and excretion.”

Trega Biosciences, Inc. is a premier provider of products that accelerate and improve drug discovery through its iDiscovery technologies linking biology and chemistry with information technologies. Trega’s iDEA Predictive ADME Simulation System of information-based models simulate, in silico, how drug candidates will be processed in the body, thereby enabling selection of those with optimal characteristics for clinical development. Together with its iDEA products, Trega’s Chem.Folio libraries of information-enhanced small molecules are designed to facilitate the identification and optimization of drug candidates. For additional information on Trega, please visit our Web site at http://www.trega.com .

============================================================

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industry updates delivered to you every week!

Q&A with Nvidia’s Chief of DGX Systems on the DGX-GB200 Rack-scale System

March 27, 2024

Pictures of Nvidia's new flagship mega-server, the DGX GB200, on the GTC show floor got favorable reactions on social media for the sheer amount of computing power it brings to artificial intelligence.  Nvidia's DGX Read more…

Call for Participation in Workshop on Potential NSF CISE Quantum Initiative

March 26, 2024

Editor’s Note: Next month there will be a workshop to discuss what a quantum initiative led by NSF’s Computer, Information Science and Engineering (CISE) directorate could entail. The details are posted below in a Ca Read more…

Waseda U. Researchers Reports New Quantum Algorithm for Speeding Optimization

March 25, 2024

Optimization problems cover a wide range of applications and are often cited as good candidates for quantum computing. However, the execution time for constrained combinatorial optimization applications on quantum device Read more…

NVLink: Faster Interconnects and Switches to Help Relieve Data Bottlenecks

March 25, 2024

Nvidia’s new Blackwell architecture may have stolen the show this week at the GPU Technology Conference in San Jose, California. But an emerging bottleneck at the network layer threatens to make bigger and brawnier pro Read more…

Who is David Blackwell?

March 22, 2024

During GTC24, co-founder and president of NVIDIA Jensen Huang unveiled the Blackwell GPU. This GPU itself is heavily optimized for AI work, boasting 192GB of HBM3E memory as well as the the ability to train 1 trillion pa Read more…

Nvidia Appoints Andy Grant as EMEA Director of Supercomputing, Higher Education, and AI

March 22, 2024

Nvidia recently appointed Andy Grant as Director, Supercomputing, Higher Education, and AI for Europe, the Middle East, and Africa (EMEA). With over 25 years of high-performance computing (HPC) experience, Grant brings a Read more…

Q&A with Nvidia’s Chief of DGX Systems on the DGX-GB200 Rack-scale System

March 27, 2024

Pictures of Nvidia's new flagship mega-server, the DGX GB200, on the GTC show floor got favorable reactions on social media for the sheer amount of computing po Read more…

NVLink: Faster Interconnects and Switches to Help Relieve Data Bottlenecks

March 25, 2024

Nvidia’s new Blackwell architecture may have stolen the show this week at the GPU Technology Conference in San Jose, California. But an emerging bottleneck at Read more…

Who is David Blackwell?

March 22, 2024

During GTC24, co-founder and president of NVIDIA Jensen Huang unveiled the Blackwell GPU. This GPU itself is heavily optimized for AI work, boasting 192GB of HB Read more…

Nvidia Looks to Accelerate GenAI Adoption with NIM

March 19, 2024

Today at the GPU Technology Conference, Nvidia launched a new offering aimed at helping customers quickly deploy their generative AI applications in a secure, s Read more…

The Generative AI Future Is Now, Nvidia’s Huang Says

March 19, 2024

We are in the early days of a transformative shift in how business gets done thanks to the advent of generative AI, according to Nvidia CEO and cofounder Jensen Read more…

Nvidia’s New Blackwell GPU Can Train AI Models with Trillions of Parameters

March 18, 2024

Nvidia's latest and fastest GPU, codenamed Blackwell, is here and will underpin the company's AI plans this year. The chip offers performance improvements from Read more…

Nvidia Showcases Quantum Cloud, Expanding Quantum Portfolio at GTC24

March 18, 2024

Nvidia’s barrage of quantum news at GTC24 this week includes new products, signature collaborations, and a new Nvidia Quantum Cloud for quantum developers. Wh Read more…

Houston We Have a Solution: Addressing the HPC and Tech Talent Gap

March 15, 2024

Generations of Houstonian teachers, counselors, and parents have either worked in the aerospace industry or know people who do - the prospect of entering the fi Read more…

Alibaba Shuts Down its Quantum Computing Effort

November 30, 2023

In case you missed it, China’s e-commerce giant Alibaba has shut down its quantum computing research effort. It’s not entirely clear what drove the change. Read more…

Nvidia H100: Are 550,000 GPUs Enough for This Year?

August 17, 2023

The GPU Squeeze continues to place a premium on Nvidia H100 GPUs. In a recent Financial Times article, Nvidia reports that it expects to ship 550,000 of its lat Read more…

Shutterstock 1285747942

AMD’s Horsepower-packed MI300X GPU Beats Nvidia’s Upcoming H200

December 7, 2023

AMD and Nvidia are locked in an AI performance battle – much like the gaming GPU performance clash the companies have waged for decades. AMD has claimed it Read more…

DoD Takes a Long View of Quantum Computing

December 19, 2023

Given the large sums tied to expensive weapon systems – think $100-million-plus per F-35 fighter – it’s easy to forget the U.S. Department of Defense is a Read more…

Synopsys Eats Ansys: Does HPC Get Indigestion?

February 8, 2024

Recently, it was announced that Synopsys is buying HPC tool developer Ansys. Started in Pittsburgh, Pa., in 1970 as Swanson Analysis Systems, Inc. (SASI) by John Swanson (and eventually renamed), Ansys serves the CAE (Computer Aided Engineering)/multiphysics engineering simulation market. Read more…

Choosing the Right GPU for LLM Inference and Training

December 11, 2023

Accelerating the training and inference processes of deep learning models is crucial for unleashing their true potential and NVIDIA GPUs have emerged as a game- Read more…

Intel’s Server and PC Chip Development Will Blur After 2025

January 15, 2024

Intel's dealing with much more than chip rivals breathing down its neck; it is simultaneously integrating a bevy of new technologies such as chiplets, artificia Read more…

Baidu Exits Quantum, Closely Following Alibaba’s Earlier Move

January 5, 2024

Reuters reported this week that Baidu, China’s giant e-commerce and services provider, is exiting the quantum computing development arena. Reuters reported � Read more…

Leading Solution Providers

Contributors

Comparing NVIDIA A100 and NVIDIA L40S: Which GPU is Ideal for AI and Graphics-Intensive Workloads?

October 30, 2023

With long lead times for the NVIDIA H100 and A100 GPUs, many organizations are looking at the new NVIDIA L40S GPU, which it’s a new GPU optimized for AI and g Read more…

Shutterstock 1179408610

Google Addresses the Mysteries of Its Hypercomputer 

December 28, 2023

When Google launched its Hypercomputer earlier this month (December 2023), the first reaction was, "Say what?" It turns out that the Hypercomputer is Google's t Read more…

AMD MI3000A

How AMD May Get Across the CUDA Moat

October 5, 2023

When discussing GenAI, the term "GPU" almost always enters the conversation and the topic often moves toward performance and access. Interestingly, the word "GPU" is assumed to mean "Nvidia" products. (As an aside, the popular Nvidia hardware used in GenAI are not technically... Read more…

Shutterstock 1606064203

Meta’s Zuckerberg Puts Its AI Future in the Hands of 600,000 GPUs

January 25, 2024

In under two minutes, Meta's CEO, Mark Zuckerberg, laid out the company's AI plans, which included a plan to build an artificial intelligence system with the eq Read more…

Google Introduces ‘Hypercomputer’ to Its AI Infrastructure

December 11, 2023

Google ran out of monikers to describe its new AI system released on December 7. Supercomputer perhaps wasn't an apt description, so it settled on Hypercomputer Read more…

China Is All In on a RISC-V Future

January 8, 2024

The state of RISC-V in China was discussed in a recent report released by the Jamestown Foundation, a Washington, D.C.-based think tank. The report, entitled "E Read more…

Intel Won’t Have a Xeon Max Chip with New Emerald Rapids CPU

December 14, 2023

As expected, Intel officially announced its 5th generation Xeon server chips codenamed Emerald Rapids at an event in New York City, where the focus was really o Read more…

IBM Quantum Summit: Two New QPUs, Upgraded Qiskit, 10-year Roadmap and More

December 4, 2023

IBM kicks off its annual Quantum Summit today and will announce a broad range of advances including its much-anticipated 1121-qubit Condor QPU, a smaller 133-qu Read more…

  • arrow
  • Click Here for More Headlines
  • arrow
HPCwire